Form 144 Vaxcyte For: 1 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Vaxcyte Inc (PCVX)
Vaxcyte Inc stock price live, this page displays NASDAQ PCVX stock exchange data. View the PCVX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Vaxcyte Inc real time stock price chart below.
What Is the Vaxcyte Inc Stock Price Today?
The Vaxcyte Inc stock price today is 58.39.
What Is the Stock Symbol for Vaxcyte Inc?
The stock symbol for Vaxcyte Inc is "PCVX."
What Stock Exchange Does Vaxcyte Inc Trade On?
Vaxcyte Inc is listed and trades on the NASDAQ stock exchange.
Is Vaxcyte Inc a Good Stock to Buy?
Determining whether Vaxcyte Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PCVX quote. (ISIN: US92243G1085)
What Is the Vaxcyte Inc Stock Price Today?
The Vaxcyte Inc stock price today is 58.39.
What Is the Stock Symbol for Vaxcyte Inc?
The stock symbol for Vaxcyte Inc is "PCVX."
What Stock Exchange Does Vaxcyte Inc Trade On?
Vaxcyte Inc is listed and trades on the NASDAQ stock exchange.
Is Vaxcyte Inc a Good Stock to Buy?
Determining whether Vaxcyte Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PCVX quote. (ISIN: US92243G1085)
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
55.62
58.49
52 wk Range
29.08
65.00
PCVX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
55.6258.49
52 wk Range
29.0865.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PCVX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
109.00
Upside
+86.68%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 4 Vaxcyte Inc For: 26 June
- Investing.com
- Form 8K Vaxcyte Inc For: 23 June
- Investing.com
- Form 144 Vaxcyte For: 1 July
- Investing.com
- Form 4 Vaxcyte Inc For: 26 June
- Investing.com
- Form 144 Vaxcyte For: 26 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
10 Buy
1 Hold
0 Sell
Ratings:
11 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 109.00
(+86.68% Upside)
Earnings
Latest Release
May 06, 2026
EPS / Forecast
-2.30 / -1.78
Revenue / Forecast
-- / 9.38M
Compare PCVX to Peers and Sector
Metrics to compare | PCVX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPCVXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.9x | −7.9x | −0.4x | |
PEG Ratio | 0.12 | −0.24 | 0.00 | |
Price/Book | 2.8x | 3.8x | 2.6x | |
Price / LTM Sales | - | 197.5x | 3.0x | |
Upside (Analyst Target) | 88.4% | 51.4% | 50.7% | |
Fair Value Upside | Unlock | −14.1% | 6.5% | Unlock |
Vaxcyte, Inc., a clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent carrier-sparing investigational pneumococcal conjugate vaccine (PCV) for the prevention of invasive pneumococcal disease (IPD) in infants. The company also develops VAX-31, a 31-valent, carrier-sparing investigational PCV for the prevention of IPD in adults and children; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting the keystone pathogen responsible for periodontitis; VAX-GI, a novel preclinical vaccine candidate for the treatment of dysentery and shigellosis, which is caused by Shigella bacteria; and VAX-XL, a third-generation pneumococcal conjugate vaccine. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Vaxcyte (PCVX) Stock Price Today?
The Vaxcyte stock price today is 58.39 USD.
What Stock Exchange Does Vaxcyte Trade On?
Vaxcyte is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Vaxcyte?
The stock symbol for Vaxcyte is "PCVX."
What Is the Vaxcyte Market Cap?
As of today, Vaxcyte market cap is 8.43B USD.
What Is Vaxcyte's Earnings Per Share (TTM)?
The Vaxcyte EPS (TTM) is -6.91.
When Is the Next Vaxcyte Earnings Date?
Vaxcyte will release its next earnings report on Aug 12, 2026.
From a Technical Analysis Perspective, Is PCVX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Vaxcyte Stock Split?
Vaxcyte has split 0 times.
How Many Employees Does Vaxcyte Have?
Vaxcyte has 507 employees.
What is the current trading status of Vaxcyte (PCVX)?
As of Jul 04, 2026, Vaxcyte (PCVX) is trading at a price of 58.39 USD, with a previous close of 56.08 USD. The stock has fluctuated within a day range of 55.62 USD to 58.49 USD, while its 52-week range spans from 29.08 USD to 65.00 USD.
What Is Vaxcyte (PCVX) Price Target According to Analysts?
The average 12-month price target for Vaxcyte is 109.00 USD, with a high estimate of 163 USD and a low estimate of 67 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +86.68% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.